EX-8.1
Published on
Exhibit 8.1
Company Subsidiaries
Novogen Limited is a company limited by shares and is incorporated and domiciled in Australia.
Novogen Limited has prepared a consolidated financial report incorporating the entities that it
controlled during the financial year ended June 30, 2008, which included the following:
| Name of Entity | Country of Incorporation | Ownership % | ||||
Novogen Laboratories Pty Ltd |
Australia | 100 | ||||
Novogen Research Pty Ltd |
Australia | 100 | ||||
Central Coast Properties Pty Ltd |
Australia | 100 | ||||
Phytosearch Pty Ltd |
Australia | 100 | ||||
Phytogen Pty Ltd |
Australia | 100 | ||||
Glycotex Pty Ltd |
Australia | 100 | ||||
Norvogen Pty Ltd |
Australia | 100 | ||||
Novogen Inc |
U.S.A. | 100 | ||||
Glycotex, Inc. |
U.S.A. | 81.0 | ||||
Novogen Limited(U.K.) |
U.K. | 100 | ||||
Promensil Limited |
U.K. | 100 | ||||
Novogen BV |
Netherlands | 100 | ||||
Novogen New Zealand Limited |
New Zealand | 100 | ||||
Novogen Canada Limited |
Canada | 100 | ||||
Marshall Edwards, Inc. |
U.S.A. | 71.9 | ||||
Marshall Edwards Pty Limited* |
Australia | 71.9 | ||||
| * | Owned indirectly through Marshall Edwards, Inc. |
At the date of this report, Novogen owns 71.3% of Marshall Edwards, Inc. and Marshall Edwards Pty
Limited.